Skip to content
StockMarketAgent
Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

HEL/PIHLIS stock hub

HEL/PIHLIS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

HEL/PIHLISis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
245.5M
Nasdaq Helsinki
Market data

Price

Recent price action with selectable time range.

HEL/PIHLISHEL/PIHLIS
Loading chart…
In the news

Latest news · HEL/PIHLIS

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E7.9
P25 n/aP50 n/aP75 n/a
Trailing P/E7.5
P25 n/aP50 n/aP75 n/a
ROE20.7
P25 n/aP50 n/aP75 n/a
ROIC7.4
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All HEL/PIHLIS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
234
Groups with data
11
Currency
EUR
Showing 234 of 234 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Finland
Country code
FI
Employees
4,096
Employees Change
-2,205%
Employees Change Percent
-34.99
Enterprise value
EUR 533.6M
Exchange
Nasdaq Helsinki
Financial currency
EUR
First seen
2026-05-10
Industry
Medical Care Facilities
Isin
FI4000092556
Last refreshed
2026-05-10
Market cap
EUR 245.5M
Price
EUR 10.92
Price currency
EUR
Rev Per Employee
149,713.87x
Sector
Healthcare
Sic
8062
Symbol
hel/PIHLIS
Website
https://www.pihlajalinna.fi

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
13.47%
EV Earnings
16.14x
EV/EBIT
13.43x
EV/EBITDA
5.56x
EV/FCF
10.51x
EV/Sales
0.87x
FCF yield
20.68%
Forward P/E
7.93x
P/B ratio
1.46x
P/E ratio
7.48x
P/S ratio
0.4x
PE Ratio10 Y
37.27x
PE Ratio3 Y
18.93x
PE Ratio5 Y
17.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

26
MetricValue
EBIT Margin
6.48%
EBITDA Margin
10.41%
FCF margin
8.28%
Gross margin
27.12%
Gross Profit
EUR 166.3M
Gross Profit Growth
-8.86%
Gross Profit Growth Q
-14.62%
Gross Profit Growth3 Y
5.62%
Gross Profit Growth5 Y
11.14%
Net Income
EUR 33.1M
Net Income Growth
12.29%
Net Income Growth Q
-23.64%
Net Income Growth Years
2%
Net Income Growth3 Y
50.92%
Net Income Growth5 Y
22.71%
Pretax Margin
6.79%
Profit Margin
5.71%
Profit Per Employee
EUR 8,073
Profitable Years
14
ROA
4.11
Roa5y
3.14
ROCE
8.99
ROE
20.66
Roe5y
13.28
ROIC
7.42
Roic5y
5.39

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

25
MetricValue
Cagr10y
-2.5%
Cagr1y
-18.96%
Cagr3y
9.1%
Cagr5y
0.62%
Div CAGR3
20.89%
Div CAGR5
21.52%
EPS Growth
12.29
EPS Growth Q
-25.53
EPS Growth Years
2
EPS Growth3 Y
50.87
EPS Growth5 Y
22.84
FCF Growth
-38.93%
FCF Growth Q
-38.61%
FCF Growth3 Y
10.08%
FCF Growth5 Y
14.75%
OCF Growth
-28.69%
OCF Growth Q
-29.07%
OCF Growth10 Y
10.62%
OCF Growth3 Y
-0.16%
OCF Growth5 Y
13.46%
Revenue Growth
-12.66x
Revenue Growth Q
-21.67x
Revenue Growth Years
0x
Revenue Growth3 Y
-5.09x
Revenue Growth5 Y
3.53x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
EUR 1.02
Assets
EUR 575.1M
Cash
EUR 11.9M
Current Assets
EUR 72M
Current Liabilities
EUR 133.3M
Debt
EUR 297.7M
Debt EBITDA
EUR 3.1
Debt Equity
EUR 1.77
Debt FCF
EUR 5.87
Equity
EUR 167.8M
Interest Coverage
5.55
Liabilities
EUR 407.3M
Long Term Assets
EUR 503.1M
Long Term Liabilities
EUR 274M
Net Cash
EUR -285.8M
Net Cash By Market Cap
EUR -116
Net Debt EBITDA
EUR 4.48
Net Debt Equity
EUR 1.7
Net Debt FCF
EUR 5.63
Tangible Book Value
EUR -102.9M
Tangible Book Value Per Share
EUR -4.58
WACC
3.37

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
0.54
Inventory Turnover
105.2
Net Working Capital
EUR -41.4M
Quick ratio
0.51
Working Capital
EUR -61.3M
Working Capital Turnover
EUR -11.13

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
-0.04%
Dividend Growth
39.47%
Dividend Growth Years
1%
Dividend per share
EUR 0.53
Dividend Years
3
Dividend Yield
4.85%
Ex Div Date
2026-04-01
Last Dividend
EUR 0.53
Payout Frequency
Annual
Payout Ratio
31.32%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
-22.33%
1Y total return
-18.95%
200-day SMA
14.45
3Y total return
29.86%
50-day SMA
12.25
50-day SMA vs 200-day SMA
50under200
5Y total return
3.12%
All Time High
19.85
All Time High Change
-44.99%
All Time High Date
2015-12-09
All Time Low
6.82
All Time Low Change
60.12%
All Time Low Date
2023-03-27
ATR
0.36
Beta
0.13
Beta1y
0.54
Beta2y
0.39
Ch YTD
-25.21
High
11.08
High52
17.3
High52 Date
2025-09-15
High52ch
-36.88%
Low
10.88
Low52
10.46
Low52 Date
2026-04-28
Low52ch
4.4%
Ma50ch
-10.86%
Price vs 200-day SMA
-24.41%
RSI
39.37
RSI Monthly
40.82
RSI Weekly
29.17
Sharpe ratio
-0.83x
Sortino ratio
-0.9
Total Return
4.81%
Tr YTD
-22
Tr1m
-7.46%
Tr1w
-1.09%
Tr3m
-22.79%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
EUR 39.7M
Operating Income Growth
-22.31
Operating Income Growth Q
-26.28
Operating Income Growth3 Y
30.8
Operating Income Growth5 Y
13.4
Operating margin
6.48

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
12,702,492%
Net Borrowing
-44,919,000
Shares Insiders
3.81%
Shares Institutions
14.99%
Shares Out
22,480,085
Shares Qo Q
0.01%
Shares Yo Y
0.04%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

60
MetricValue
Adjusted FCF
EUR 50.8M
Average Volume
27,769.35x
Bv Per Share
7.36
CAPEX
EUR -17.3M
Ch10y
-33.41
Ch1m
-7.46
Ch1w
-1.09
Ch1y
-22.28
Ch3m
-25.97
Ch3y
19.87
Ch5y
-7.14
Ch6m
-24.95
Change
-1.8%
Change From Open
-0.91
Close
11.12
Days Gap
-0.9
Depreciation Amortization
24,125,000
Dollar Volume
154,365.1
Earnings Date
2026-04-28
EBIT
EUR 39.7M
EBITDA
EUR 63.9M
EPS
EUR 1.46
F Score
6
FCF
EUR 50.8M
FCF EV Yield
9.51x
FCF Per Share
EUR 2.26
Financing CF
-87,714,000
Fiscal Year End
December
Founded
2,014
Goodwill
253,600,000
Graham Number
15.55148
Graham Upside
42.41
Income Tax
EUR 6M
Investing CF
-4,581,000
Is Primary Listing
1
Last Earnings Date
2026-04-28
Last Report Date
2026-03-31
Lynch Fair Value
EUR 33.15
Lynch Upside
203.6
Ma150
13.86
Ma150ch
-21.22%
Ma20
11.46
Ma20ch
-4.74%
Net CF
-24,332,000
Next Earnings Date
2026-07-23
Open
11.02
P FCF Ratio
4.84
P OCF Ratio
3.61
Payment Date
2026-04-13
Position In Range
20
Ppne
223,000,000
Price Date
2026-05-08
Price EBITDA
EUR 3.84
Relative Volume
0.51x
Revenue
613,228,000x
Tax By Revenue
0.97x
Tax Rate
14.32%
Tr6m
-21.73%
Volume
14,136
Z Score
1.77
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

HEL/PIHLIS dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+4.9%
$0.53 annual per share
Payout ratio
+31.3%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+21.5%
1 consecutive years of growth
Total shareholder yield
+4.8%
Next ex-dividend date: 2026-04-01
Performance

HEL/PIHLIS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-18.9%
S&P 500 1Y: n/a
3Y total return
+29.9%
S&P 500 3Y: n/a
5Y total return
+3.1%
S&P 500 5Y: n/a
10Y total return
-22.3%
S&P 500 10Y: n/a
Ownership

Who owns HEL/PIHLIS?

Insider, institutional, and short-interest positioning.

Institutional ownership
+15.0%
Share of float held by funds and institutions
Insider ownership
+3.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.0%
Negative means the company is buying back shares.
Technical

HEL/PIHLIS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
39.4
Neutral momentum band
Price vs 200-day MA
-24.4%
50/200-day relationship not available
Beta (5Y)
0.13
Less volatile than the market
Sharpe ratio
-0.83
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About HEL/PIHLIS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hel/PIHLIS stock rating?

hel/PIHLIS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hel/PIHLIS analysis?

The full report lives at /stocks/hel/PIHLIS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hel/PIHLIS?

The latest report frames hel/PIHLIS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hel/PIHLIS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.